Introduction: Endometrial hyperplasia produces a continuum of lesions that may be precursor to endometrial carcinoma of endometrioid histology. The World Health Organization (WHO) classification is currently the most commonly accepted system of classifying endometrial hyperplasias, the problems with which have prompted the development of an alternative system based on Endometrial Intraepithelial Neoplasia (EIN).Materials and Methods: We undertook the study using revised EIN criteria to differentiate EIN lesions from lookalikes. EIN diagnostic criteria's, such as gland area>stromal area, cytologic change in focus of altered architecture, lesion size>1 mm and exclusion of cancer and mimics were applied on two hundred endometrial biopsies that were initially classified as hyperplasia using WHO classification system.Results: Out of total two hundred cases, 41.5% were diagnosed as simple typical hyperplasia, 19% cases as complex typical hyperplasia, 9.5% cases as simple atypical hyperplasia and 30% cases as complex atypical hyperplasia respectively. Out of these WHO classified hyperplasias, 39% were re-classified as EIN and 61% as non-EIN lesions. Majority of WHO classified atypical hyperplasias were reclassified as EIN. Conclusion: EIN criterias can easily be applied to routine haematoxylin and eosin stained sections and is more reproducible than WHO system of classification. Few of the lesions diagnosed as simple hyperplasia without atypia correspond to EIN and have a worse prognosis. EIN successfully segregates patients into high and low cancer risk groups.
INTRODUCTION
Due to inadequately supported reproductive pathologic criteria's in existing World Health Organization (WHO) classification of endometrial hyperplasia, the diagnosis of precancerous lesions of the endometrium remains unstandardized 1 . There are many shortcomings in the WHO endometrial hyperplasia classification system that subclassifies hyperplasia by cytology as atypical / non atypical and architecture as complex / non complex. 2, 3 Overall reproducibility of atypical hyperplasia diagnosis is poor, because of nonspecific reporting patterns and intra/inter-observer variation which leads to confusion among clinicians and pathologists. The Endometrial Collaborative Group, an international group of 19 pathologists has recently attempted to clarify the concept of endometrial neoplasia and proposed two categories of endometrial lesions, endometrial hyperplasia and endometrial neoplasia, the latter divided into intra-epithelial and invasive neoplasia. True endometrial hyperplasia rarely progresses to neoplasia while lesions formerly designated as "atypical hyperplasia" are presently reclassified as Endometrial Intraepithelial Neoplasia (EIN), which carries a significant risk of progression into invasive carcinoma 4, 5 .
According to Endometrial Collaborative Group, there are many advantages to diagnose premalignant endometrial disease as EIN such as 1) Pre-cancers should be placed in a single diagnostic category 2) Pre-cancers are monoclonal and thus neoplastic and parallelism with other pre-cancerous nomenclature systems elsewhere in the female genital tract is required 3) Endometria which do not meet diagnostic criteria for EIN can be diagnosed as "Endometrial Hyperplasia" to distinguish them from EIN lesions. Long term prospective multicenter studies have shown that the EIN system is prognostically superior then other commonly used systems 9 . Based on these considerations, the present study was designed to review Endometrial Intraepithelial Neoplasia (EIN) and to correlate it with WHO classification of endometrial hyperplasia.
MATERIALS AND METHODS
Two hundred patients who were not on therapeutic hormones and who presented with abnormal vaginal bleeding were included in this study. The histopathological material consisted of dilatation and curettage, endometrial biopsy and hysterectomy specimen. The material was fixed in 10% formalin and processed in graded alcohol and xylene, embedded in paraffin wax and thin sections were taken on pre-labelled slides. The hydrated sections were then subjected to haematoxylin and eosin staining. Two pathologists separately examined the slides using the WHO hyperplasia classification system which was considered as primary diagnosis and then reclassified these lesions as Endometrial Intraepithelial Neoplasia using EIN criterias 6 such as 1) Glandular crowding (volume percentage stroma < 55%): EIN lesions have a stromal volume less than that of the glands 2) Cytologic demarcation: EIN lesions have an abnormal cytology within the crowded glands comprising an EIN focus. 3) Size of the lesion should exceed 1mm. 4) exclude confounding benign processes like secretory endometrium, polyps, repair etc. 5) exclude carcinoma. The percentages of each WHO hyperplasia category that was reclassified as EIN were then determined and classified as EIN lesion or Non-EIN lesion.
RESULTS
In the present study, two hundred cases of various endometrial hyperplastic lesions were examined, out of which majority of patients with WHO classified endometrial hyperplasias were from 4 th and 5 th decade of life whereas Endometrial Intraepithelial Neoplasia lesions were more prevalent in 5 th decade of life. As shown in table 1; out of total two hundred cases, 41.5% were diagnosed as simple typical hyperplasia, 19% cases as complex typical hyperplasia, 9.5% cases as simple atypical hyperplasia and 30% cases as complex atypical hyperplasia respectively. The number of cases of simple typical hyperplasias in the present study was found to be similar with the study done by Kurman et al 8 Seventy eight cases (39%) of EIN lesions were re-diagnosed from two hundred cases of WHO classified endometrial hyperplasia which was relatively similar to study done by Hecht et al 11 . Table 3 shows comparison of WHO classified simple typical hyperplasia, complex typical hyperplasia and atypical hyperplasias with EIN as studied by different authors. 
